Results 101 to 110 of about 6,382 (203)

Antibiotics – rifamycins [PDF]

, 2010

core   +1 more source

New Structure Activity Relationship Insight into the Role of the C-3 Extension on Rifamycin Antimycobacterial Activity. [PDF]

ChemMedChem
Veale CGL, Smolarz E, Leśniewska A, Pyta K, Przybylski P.   +4 more
europepmc   +1 more source

Next-generation rifamycins for the treatment of mycobacterial infections. [PDF]

Proc Natl Acad Sci U S A
Dartois V, Lan T, Ganapathy US, Wong CF, Sarathy JP, Jimenez DC, Alshiraihi IM, Lam H, Rodriguez S, Xie M, Soto-Ojeda M, Jackson M, Wheat W, Dillman NC, Kostenkova K, Schmitt J, Mann L, Richter A, Imming P, Sarathy J, Kaya F, Paruchuri S, Tatek B, Folvar C, Proietto J, Zimmerman M, Gonzalez-Juarrero M, Aldrich CC, Dick T.   +28 more
europepmc   +1 more source

Immunosuppression by Rifamycins [PDF]

, 1982
G. Bolzoni, L. Bassi
core   +1 more source

Probiotics and Antibiotics: From Empirical Practice to a Biological Rationale for Targeted Choice During Antibiotic Therapy. [PDF]

Microorganisms
Matera M, Biagioli V, Leo S, Drago L.
europepmc   +1 more source

Thiazo rifamycins—I [PDF]

, 1980
P. Antonini, G. Tamborini, R.J. White, R. Cricchio, E. Martinelli, G.C. Lancini   +5 more
core   +1 more source

A Case of Evolving Hepatotoxicity Following Systemic Drug Reaction to Isoniazid-Rifapentine (3HP). [PDF]

Case Reports Hepatol
Vizgan N, Martinez-Kratz J, LaBudde C, Gordon F.   +3 more
europepmc   +1 more source

Rifamycins and Other Ansamycins [PDF]

, 1975
W. Wehrli, M. Staehelin
core   +1 more source

Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion. [PDF]

Transpl Infect Dis
Simkins J, Viotti JB, Natori Y, Anjan S, Mattiazzi A, Ortigosa-Goggins M, Guerra G, Roth D, Kupin W, Pagan JA, Cabeza F, Ciancio G, Morsi M, Morris MI.   +13 more
europepmc   +1 more source

Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention. [PDF]

Microbiol Spectr
Madzime RJ, van der Laan L, du Toit S, Barnabas S, Courtney I, Brown NE, Savic R, Solans BP, Dixon MG, Tsirizani L, Denti P, Boyd R, Hesseling AC, TBTC Study 35 team.   +13 more
europepmc   +1 more source